Diagnostic or therapeutic injection of an anaesthetic, with or without a steroid, at a named nerve or plexus, billed with the injection code and, where used, imaging guidance.
What the independent reviewers decided
61%
overturned by the independent reviewer
133
of 217 decisions in the corpus
Source
California DMHC independent medical review determinations, 2017-2026. Public record.
Read this as a base rate, not as your odds
Why plans deny nerve block
- The policy requires documented conservative management before an interventional procedure and the record does not evidence it.
- A repeat block is denied because the response to the previous one is not documented in the terms the policy asks for.
- The number of blocks in a period exceeds a policy limit.
- The block is characterised as a treatment for a condition the policy considers unproven for this indication.
What actually carried the cases that won
Prior treatment led the overturned decisions, and the corpus is specific about what counts: therapy tried, medication tried, and — where a block had already been given — what the response actually was, in duration and degree. Records that reported a prior block's result numerically fared better than those describing it as helpful. Peer-reviewed literature and clinical guidelines were the reviewers' main authorities.
| What the record showed | Share of overturned decisions |
|---|---|
| Prior treatment was documented | 69% |
| The condition was documented as chronic or long-standing | 61% |
| Conservative treatment was documented as failed | 51% |
| A published guideline supported the request | 42% |
| The severity or urgency was documented | 37% |
| Objective findings were documented | 26% |
| The diagnosis was confirmed | 19% |
| The functional impact on the patient was documented | 15% |
Shares are of the overturned decisions and do not sum to 100% — a single decision often rested on more than one, and some rested on none of these.
What the reviewers cited
- Peer-reviewed literature — in 56% of the overturned decisions
- Clinical guidelines — in 13% of the overturned decisions
- Specialty-society criteria — in 5% of the overturned decisions
- Standard of care — in 3% of the overturned decisions
- FDA labeling — in 2% of the overturned decisions
nerve block denials — frequently asked
Is a denied nerve block worth appealing?
How should a prior block be documented?
Does imaging guidance change the analysis?
Related guides
Denial reasons and criteria are described in plain language for reference and vary by plan and policy. This page reports what independent reviewers decided in a public California dataset; it is general information, not medical, legal, or coverage advice.
When the appeal has to be written, and cited
Upload the denied EOB and Merits returns a complete, citation-verified appeal letter — the clinical argument, the payer's own coverage criteria, and your federal appeal rights — in about a minute.
